NatureCellLtd (A007390) Stock Overview
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
A007390 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
NatureCell Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩20,600.00 |
| 52 Week High | ₩39,350.00 |
| 52 Week Low | ₩15,260.00 |
| Beta | 0.078 |
| 1 Month Change | -6.15% |
| 3 Month Change | 0.98% |
| 1 Year Change | 0.73% |
| 3 Year Change | 26.77% |
| 5 Year Change | 115.48% |
| Change since IPO | 1,038.12% |
Recent News & Updates
We're Interested To See How NatureCellLtd (KOSDAQ:007390) Uses Its Cash Hoard To Grow
Oct 19
Risks Still Elevated At These Prices As NatureCell Co.,Ltd. (KOSDAQ:007390) Shares Dive 27%
May 22NatureCell Co.,Ltd.'s (KOSDAQ:007390) Share Price Not Quite Adding Up
Mar 21Here's Why We're Not Too Worried About NatureCellLtd's (KOSDAQ:007390) Cash Burn Situation
Dec 30NatureCell Co.,Ltd. (KOSDAQ:007390) Stock Rockets 88% As Investors Are Less Pessimistic Than Expected
Nov 22Recent updates
We're Interested To See How NatureCellLtd (KOSDAQ:007390) Uses Its Cash Hoard To Grow
Oct 19Risks Still Elevated At These Prices As NatureCell Co.,Ltd. (KOSDAQ:007390) Shares Dive 27%
May 22NatureCell Co.,Ltd.'s (KOSDAQ:007390) Share Price Not Quite Adding Up
Mar 21Here's Why We're Not Too Worried About NatureCellLtd's (KOSDAQ:007390) Cash Burn Situation
Dec 30NatureCell Co.,Ltd. (KOSDAQ:007390) Stock Rockets 88% As Investors Are Less Pessimistic Than Expected
Nov 22We Think NatureCellLtd (KOSDAQ:007390) Needs To Drive Business Growth Carefully
Jul 16We Think NatureCellLtd (KOSDAQ:007390) Can Easily Afford To Drive Business Growth
Mar 22Shareholder Returns
| A007390 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -5.5% | 3.8% | 7.0% |
| 1Y | 0.7% | 46.0% | 75.4% |
Return vs Industry: A007390 underperformed the KR Biotechs industry which returned 46% over the past year.
Return vs Market: A007390 underperformed the KR Market which returned 75.4% over the past year.
Price Volatility
| A007390 volatility | |
|---|---|
| A007390 Average Weekly Movement | 9.5% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A007390's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A007390's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 77 | Jeong-Chan Ra | www.naturecell.co.kr |
NatureCell Co.,Ltd. engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea. The company’s products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and other ETC products under the SAMMI and OEM brands.
NatureCell Co.,Ltd. Fundamentals Summary
| A007390 fundamental statistics | |
|---|---|
| Market cap | ₩1.36t |
| Earnings (TTM) | -₩2.87b |
| Revenue (TTM) | ₩22.12b |
Is A007390 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007390 income statement (TTM) | |
|---|---|
| Revenue | ₩22.12b |
| Cost of Revenue | ₩12.80b |
| Gross Profit | ₩9.32b |
| Other Expenses | ₩12.19b |
| Earnings | -₩2.87b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -44.49 |
| Gross Margin | 42.14% |
| Net Profit Margin | -12.96% |
| Debt/Equity Ratio | 0% |
How did A007390 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/07 09:01 |
| End of Day Share Price | 2026/01/07 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NatureCell Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.